B

Boundless Bio Inc
NASDAQ:BOLD

Watchlist Manager
Boundless Bio Inc
NASDAQ:BOLD
Watchlist
Price: 3.24 USD -9.24% Market Closed
Market Cap: 72.1m USD
Have any thoughts about
Boundless Bio Inc?
Write Note

P/E
Price to Earnings

-1.2
Current
-1.5
Median
23
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-1.2
=
Market Cap
72.1m USD
/
Net Income
-57.7m USD
All Countries
Close
Market Cap P/E
US
Boundless Bio Inc
NASDAQ:BOLD
72.1m USD -1.2
FR
Pharnext SCA
OTC:PNEXF
6T USD -179 080.5
US
Abbvie Inc
NYSE:ABBV
300.2B USD 59.1
US
Amgen Inc
NASDAQ:AMGN
158.7B USD 37.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.8B USD -264.2
US
Gilead Sciences Inc
NASDAQ:GILD
114.8B USD 910.9
US
Epizyme Inc
F:EPE
94.1B EUR -477.1
AU
CSL Ltd
ASX:CSL
137.3B AUD 33.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.3B USD 19
US
Seagen Inc
F:SGT
39.3B EUR -55.2
NL
argenx SE
XBRU:ARGX
34.1B EUR -129.5
Earnings Growth
US
B
Boundless Bio Inc
NASDAQ:BOLD
Average P/E: 212
Negative Multiple: -1.2
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -179 080.5 N/A
US
Abbvie Inc
NYSE:ABBV
59.1
412%
US
Amgen Inc
NASDAQ:AMGN
37.5
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -264.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
910.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -477.1 N/A
AU
CSL Ltd
ASX:CSL
33.5
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.5 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-0.5
2-Years Forward
P/E
-0.8
3-Years Forward
P/E
-0.7

See Also

Discover More